Wéclawiak, Hugo <br/><br/>
Biological agents in kidney transplantation: belatacept is entering the field.  [electronic resource] 

 -  Expert opinion on biological therapy  Oct 2010 
 - 1501-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.2010.514901  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abatacept<br/>Animals<br/>Calcineurin Inhibitors<br/>Drug Therapy, Combination<br/>Graft Rejection--immunology<br/>Graft Survival--drug effects<br/>Humans<br/>Immunoconjugates--adverse effects<br/>Immunosuppressive Agents--adverse effects<br/>Kidney Transplantation--immunology<br/>Sirolimus--therapeutic use<br/>Time Factors<br/>Transplantation, Homologous<br/>Treatment Outcome